Alpine Global Management, LLC Alaunos Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.62 - $1.17 $71,675 - $135,257	-115,605 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $108,100 - $187,440	99,175 Added 603.62%	115,605 $126,000
Q2 2021 Aug 13, 2021	BUY	$2.63 - $3.67 $43,210 - $60,298	16,430 New	16,430 $43,000
Q1 2020 Apr 09, 2020	SELL	$1.9 - $4.98 $43,673 - $114,470	-22,986 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$3.95 - $5.35 $90,794 - $122,975	22,986 New	22,986 $108,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.